Genotyping the factor VIII intron 22 inversion locus using fluorescent in situ hybridization

Area of Science:

• Genetics
• Molecular Biology
• Medical Diagnostics

Background:

• The factor VIII intron 22 inversion is the primary genetic cause of severe hemophilia A, present in about 40% of cases.
• Current diagnostic methods like Southern hybridization and multiplex long-distance PCR have notable limitations.
• Accurate genetic diagnosis is crucial for effective hemophilia A management.

Purpose of the Study:

• To develop and evaluate a novel multicolor fluorescent in situ hybridization (FISH) assay.
• To establish FISH as a reliable alternative for diagnosing the factor VIII intron 22 inversion.
• To compare the performance of the FISH assay against established diagnostic techniques.

Main Methods:

• Design of a FISH assay utilizing three differentially labeled BAC DNA probes.
• Hybridization of probes to interphase nuclei to detect specific signal patterns.
• Application of the FISH assay to DNA samples from normal and inversion-positive males and carrier females.

Main Results:

• The FISH assay correctly assigned genotypes in all tested male samples (p<0.001).
• Genotyping of carrier females presented challenges, likely due to the complexity of two X chromosomes.
• The assay demonstrated favorable performance compared to conventional methods in pilot testing.

Conclusions:

• Multicolor FISH is a viable and accurate method for diagnosing the factor VIII intron 22 inversion in males.
• Further refinement may be needed to optimize genotype assignment in carrier females.
• This FISH assay presents a valuable advancement in the genetic diagnosis of hemophilia A.